Seeing a dramatic "sell the news" reaction to yesterday's FDA approval of obesity drug Belviq, today's drop in Arena Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE